Amlodipine Besylate Tablet
Product Images NDC 72789-262

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 72789-262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789260 Label (72789260)

Label for Amlodipine Besylate tablets USP 2.5 mg, package of 90 tablets. The label shows the NDC 72789-260-90, notes the product is Rx only, and includes storage instructions, manufacturer Oxford Pharmaceuticals LLC in Birmingham, Alabama, and marketer PD-Rx Pharmaceuticals, Inc. in Oklahoma City, Oklahoma. Additional details include dosage reference, barcode, expiration date 11/2023, and lot number Z99Z99.*

FDA Label Image

72789261 Label (72789261)

Label for Amlodipine Besylate Tablets USP 5 mg, containing 90 tablets. The label includes storage instructions, dosage form (tablets), and prescription-only status. Marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Oxford Pharmaceuticals, LLC, Birmingham, Alabama. The label also features a barcode, NDC 72789-261-90, and other product identifiers.*

FDA Label Image

72789262 Label (72789262)

Label for Amlodipine Besylate Tablets USP 10 mg, containing 1000 tablets. The label shows NDC 72789-262-95 and indicates Rx Only. Marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Oxford Pharmaceuticals, LLC, Birmingham, AL. Storage instructions and barcode are included.*

FDA Label Image

Figure-1 (Figure1)

A Kaplan-Meier survival curve comparing event rates over time (months) between Amlodipine and Placebo groups. The graph shows lower event rates for Amlodipine throughout the 24-month period. The chart includes a hazard ratio, confidence interval, and p-value indicating statistical analysis results.*

FDA Label Image

Figure-2 (Figure2)

A forest plot showing hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo across patient subgroups. The chart includes overall population, age groups, gender, baseline sitting systolic blood pressure, vessel disease categories, vessels with stenosis, and PCI-stent strata. The horizontal axis represents hazard ratio values from 0.0 to 2.0, with a vertical line at 1.0 indicating no effect.*

FDA Label Image

Structure (Structure)

Chemical structure of amlodipine besylate, showing the molecular diagram with labeled atoms including chlorine, oxygen, nitrogen, carbon, hydrogen, and the sulfonate group (C6H6O3S).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.